Comparative assessment of sarcopenia using the JS']JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis

被引:49
|
作者
Saeki, Chisato [1 ,2 ]
Takano, Keiko [1 ]
Oikawa, Tsunekazu [1 ]
Aoki, Yuma [1 ,2 ]
Kanai, Tomoya [1 ,2 ]
Takakura, Kazuki [1 ]
Nakano, Masanori [1 ,2 ]
Torisu, Yuichi [1 ,2 ]
Sasaki, Nobuyuki [3 ]
Abo, Masahiro [3 ]
Matsuura, Tomokazu [4 ]
Tsubota, Akihito [5 ]
Saruta, Masayuki [1 ]
机构
[1] Jikei Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med,Minato Ku, 3-2S-8 Nishi Shinbashi, Tokyo 1058461, Japan
[2] Fuji City Gen Hosp, Dept Internal Med, Div Gastroenterol, Shizuoka, Japan
[3] Jikei Univ, Dept Rehabil Med, Sch Med, Tokyo, Japan
[4] Jikei Univ, Dept Lab Med, Sch Med, Tokyo, Japan
[5] Jikei Univ, Res Ctr Med Sci, Core Res Facil, Sch Med, Tokyo, Japan
基金
日本学术振兴会;
关键词
Liver cirrhosis; Sarcopenia; Sarcopenia assessment criteria; Osteoporosis; Osteosarcopenia; Vertebral fracture; WORSE SURVIVAL; WORKING GROUP; ETIDRONATE; DISORDERS; PREDICTOR; PROGNOSIS; CONSENSUS;
D O I
10.1186/s12891-019-2983-4
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Sarcopenia and osteoporosis reduce life quality and worsen prognosis in patients with liver cirrhosis (LC). When these two complications coexist, a diagnosis of osteosarcopenia is made. We aimed to investigate the actual situations of sarcopenia, osteoporosis, osteosarcopenia, and vertebral fracture, and to clarify the relationship among these events in patients with LC. Methods: We describe a cross-sectional study of 142 patients with LC. Sarcopenia was defined according to the Japan Society of Hepatology (JSH) criteria, Asian Working Group for Sarcopenia (AWGS) criteria, and European Working Group on Sarcopenia in Older People (EWGSOP2) criteria. The skeletal muscle mass index (SMI) and handgrip strength were assessed using bioelectrical impedance analysis and a digital grip strength dynamometer, respectively. Bone mineral density (BMD) was measured using dual energy X-ray absorptiometry, and vertebral fracture was evaluated using spinal lateral X-rays. The severity of LC was assessed using the Child-Pugh classification. Results: Among the 142 patients, the prevalence of sarcopenia was 33.8% (48/142) according to the JSH and AWGS criteria and 28.2% (40/142) according to the EWGSOP2 criteria. The number of patients with osteoporosis, osteosarcopenia, and vertebral fracture was 49 (34.5%), 31 (21.8%), and 41 (28.9%), respectively. Multivariate analysis revealed a close association between sarcopenia and osteoporosis. Osteoporosis was independently associated with sarcopenia [odds ratio (OR) = 3.923, P = 0.010]. Conversely, sarcopenia was independently associated with osteoporosis (OR = 5.722, P < 0.001). Vertebral fracture occurred most frequently in patients with osteosarcopenia (19/31; 61.3%) and least frequently in those without both sarcopenia and osteoporosis (12/76; 15.8%). The SMI and handgrip strength values were significantly correlated with the BMD of the lumbar spine (r = 0.55 and 0.51, respectively; P < 0.001 for both), femoral neck, (r = 0.67 and 0.62, respectively; P < 0.001 for both), and total hip (r = 0.67 and 0.61, respectively; P < 0.001 for both). Conclusions: Sarcopenia, osteoporosis, osteosarcopenia, and vertebral fracture were highly prevalent and closely associated with one another in patients with LC. Specifically, patients with osteosarcopenia had the highest risk of vertebral fractures. Early diagnosis of these complications is essential for treatment intervention.
引用
下载
收藏
页数:12
相关论文
共 26 条
  • [1] Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis
    Chisato Saeki
    Keiko Takano
    Tsunekazu Oikawa
    Yuma Aoki
    Tomoya Kanai
    Kazuki Takakura
    Masanori Nakano
    Yuichi Torisu
    Nobuyuki Sasaki
    Masahiro Abo
    Tomokazu Matsuura
    Akihito Tsubota
    Masayuki Saruta
    BMC Musculoskeletal Disorders, 20
  • [2] The relationship between osteoporosis and sarcopenia, according to EWGSOP-2 criteria, in outpatient elderly
    Mehmet Selman Ontan
    Ozge Dokuzlar
    Esra Ates Bulut
    Pinar Soysal
    Ahmet Turan Isik
    Journal of Bone and Mineral Metabolism, 2021, 39 : 684 - 692
  • [3] The relationship between osteoporosis and sarcopenia, according to EWGSOP-2 criteria, in outpatient elderly
    Ontan, Mehmet Selman
    Dokuzlar, Ozge
    Ates Bulut, Esra
    Soysal, Pinar
    Isik, Ahmet Turan
    JOURNAL OF BONE AND MINERAL METABOLISM, 2021, 39 (04) : 684 - 692
  • [4] Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass
    Trussardi Fayh, Ana Paula
    de Sousa, Iasmin Matias
    PLOS ONE, 2021, 16 (09):
  • [5] The predictive values of sarcopenia screening tools in preoperative elderly patients with colorectal cancer: applying the diagnostic criteria of EWGSOP2 and AWGS2019
    Ling Li
    Mengchen Xing
    Rong Wang
    Xiaoyue Ding
    Xia Wan
    Xin Yu
    BMC Geriatrics, 25 (1)
  • [6] Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition
    Dietzel, Roswitha
    Wiegmann, Sabine
    Borucki, Diana
    Detzer, Christian
    Zeiner, Kim Nikola
    Schaumburg, Desiree
    Buehring, Bjoern
    Buttgereit, Frank
    Armbrecht, Gabriele
    RMD OPEN, 2022, 8 (02):
  • [7] Relationship between osteoporosis, sarcopenia, vertebral fracture, and osteosarcopenia in patients with primary biliary cholangitis
    Saeki, Chisato
    Oikawa, Tsunekazu
    Kanai, Tomoya
    Nakano, Masanori
    Torisu, Yuichi
    Sasaki, Nobuyuki
    Abo, Masahiro
    Saruta, Masayuki
    Tsubota, Akihito
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (05) : 731 - 737
  • [8] Sarcopenia assessment by new EWGSOP2 criteria for predicting chemotherapy dose-limiting toxicity in patients with gastrointestinal tract tumors
    Emir Celik
    Veysel Suzan
    Nilay Sengul Samanci
    Aysegul Akkan Suzan
    Mehmet Karadag
    Serdar Sahin
    Muhammed Samil Aslan
    Hakan Yavuzer
    Nebi Serkan Demirci
    Alper Doventas
    Fuat Hulusi Demirelli
    European Geriatric Medicine, 2022, 13 : 267 - 274
  • [9] Sarcopenia assessment by new EWGSOP2 criteria for predicting chemotherapy dose-limiting toxicity in patients with gastrointestinal tract tumors
    Celik, Emir
    Suzan, Veysel
    Samanci, Nilay Sengul
    Suzan, Aysegul Akkan
    Karadag, Mehmet
    Sahin, Serdar
    Aslan, Muhammed Samil
    Yavuzer, Hakan
    Demirci, Nebi Serkan
    Doventas, Alper
    Demirelli, Fuat Hulusi
    EUROPEAN GERIATRIC MEDICINE, 2022, 13 (01) : 267 - 274
  • [10] Sarcopenia in hospitalized geriatric patients: insights into prevalence and associated parameters using new EWGSOP2 guidelines
    Bertschi, Dominic
    Kiss, Caroline M.
    Beerli, Nadine
    Kressig, Reto W.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2021, 75 (04) : 653 - 660